Methotrexate Tablet
Product Images NDC 0904-7141

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0904-7141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7eb6a49a C6a3 4162 83e8 59f2d7ca55c1 01)

Image (7eb6a49a C6a3 4162 83e8 59f2d7ca55c1 01)
Chemical structure of Methotrexate. The diagram displays the molecular arrangement of Methotrexate, including its amino and carboxyl functional groups and sodium salt components, representing the drug's chemical composition.*
FDA Label Image

2.5mg Carton Label (5d9b7269 19d4 4d2c B252 F3ff759dffa5 00)

2.5mg Carton Label (5d9b7269 19d4 4d2c B252 F3ff759dffa5 00)
Label for Methotrexate 2.5 mg tablets by Major Pharmaceuticals. It is a unit dose package containing 20 tablets (2 x 10). The label includes NDC 0904-7141-10, and cautions the drug as a cytotoxic agent. It notes dispensing with patient information and provides storage instructions. The package is marked Rx only and intended for institutional use, with warnings about child resistance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.